What Researchers Did
Researchers conducted a scoping review to gather existing evidence on the impact of hyperbaric oxygen therapy (HBOT) on insulin resistance.
What They Found
Out of 230 studies initially found, 17 were deemed eligible for inclusion in the review. The evidence suggests that HBOT appears to improve fasting glycaemia and decrease insulin resistance in patients with diabetes mellitus, with effects potentially appearing after just one treatment session.
What This Means for Canadian Patients
Canadian patients with diabetes or at risk for type 2 diabetes might potentially benefit from hyperbaric oxygen therapy to improve insulin resistance. This could offer a novel approach to managing blood sugar levels and preventing disease progression.
Canadian Relevance
There is no direct Canadian connection or involvement mentioned in this study.
Study Limitations
A limitation of this scoping review is the potential heterogeneity and varying quality of the 17 included studies.